Application Version: 4.0.6.10
Content Version: 2024.07.12
Release Notes [PDF288KB]
User Guide [PDF6.08MB]
Code System Update Calendar
Contact Us
Subscribe
Related Links
- PHIN Vocabulary Services
- Quick Links / Mapping Tools
- External Standards Resources
- Message Guides
- Developer's Guide
- PHINVADS FHIR API
Downloads
- RCMT Quick Search
Value Set and Code System Information
Code System Name | NullFlavor |
Value Set Code | PHVS_LabTestInterpretation_Pertussis |
Value Set Name | Lab Test Interpretation (Pertussis) |
Value Set Version | 1 |
Value Set Concept Details
Concept Code | UNK |
Preferred Concept Name | Unknown |
Value Set Concept Status | Published |
Value Set Concept Status Date | 06/10/2015 |
Value Set Concept Description | |
Sequence |
Code System Concept Details
Code System Concept Name | unknown |
Code System Concept Status | Published |
Code System Preferred Concept Name | unknown |
Date Created | |
Date Revised | 05/01/2009 |
Associated Value Sets
Value Set Name | Version(s) | |
---|---|---|
Abnormal Chest X-Ray Finding (TB) | 1 | |
Abnormal Chest X-ray Condition Status | 1 | |
Activity Type (Brucellosis) | 2 , 1 | |
Activity Type (Leptospirosis) | 1 | |
Activity Type Anthrax | 1 | |
Actual Route of Administration (Anthrax) | 1 | |
Acute Convalescent IgG Difference (VPD) | 1 | |
Age Group (Flu) | 1 | |
Age Unit (NETSS) | 2 , 1 | |
Age Unit (NND) | 1 | |
Age Unit (Syndromic Surveillance) | 1 | |
Age unit | 2 , 1 | |
Alanine aminotransferase (ALT) Result (Hepatitis) | 2 , 1 | |
Animal Exposure Location (Brucellosis) | 1 | |
Animal Ownership (Brucellosis) | 2 , 1 | |
Animal Species (Animal Rabies) | 1 | |
Animal Type (Anthrax) | 1 | |
Animal Type (Brucellosis) | 1 | |
Animal Type (COVID-19) | 1 | |
Animal Type (FDD) | 3 , 2 , 1 | |
Animal Type (Leptospirosis) | 2 , 1 | |
Antacids (FDD) | 1 | |
Antibiotic Dose Units (Brucellosis) | 3 , 2 , 1 | |
Antibiotic Reason (RIBD) | 1 | |
Antibiotic Received (Pertussis) | 5 , 4 , 3 , 2 , 1 | |
Antibiotic Received (RIBD) | 2 , 1 | |
Antibiotic Treatment (NETSS) | 1 | |
Antibiotics (FDD) | 5 , 4 , 3 , 2 , 1 | |
Antimicrobials (Anthrax) | 1 | |
Assisted Living Exposure Type (RIBD) | 1 | |
Bacterial Infection Syndrome (IPD) | 1 | |
Bird Type (RIBD) | 1 | |
Birth Attendant Titles (NCHS) | 3 | |
Birth Attendees (VPD) | 1 | |
Birth Country | 7 , 6 , 5 , 4 , 3 , 2 | |
Birth Location (Listeria) | 1 | |
Birth Location (RIBD) | 1 | |
Birth Location (VPD) | 1 | |
Birth Outcome (Rubella) | 2 , 1 | |
Birth Outcome (VPD) | 1 | |
Birth Status (NND) | 1 | |
Birth or Delivery Occurred (NCHS) | 2 | |
Blood Contact Frequency (Hepatitis) | 1 | |
Blood Product | 1 | |
Body Region(s) of Rash | 2 , 1 | |
Brucella Exposure (Brucellosis) | 2 , 1 | |
CSF WBC Protein Result (NND) | 1 | |
Campylobacter Nonculture Test Type (BIDS) | 1 | |
Case Class Status (NETSS) | 1 | |
Case Classification Exposure Source | 2 , 1 | |
Case Classification Status | 1 | |
Case Detection Method | 3 , 2 | |
Case Investigation Status | 3 , 2 | |
Case Traced to Carrier | 1 | |
Case Transmission Mode (BIDS) | 1 | |
Case Type (CP-CRE) | 1 | |
Cause of Death Related to TB | 1 | |
Character of Lesions | 2 , 1 | |
Chest XRay Result | 1 | |
Clinical Finding (COVID-19) | 1 | |
Clinical Manifestations (Anthrax) | 1 | |
Clinical Manifestations (Brucellosis) | 1 | |
Clinical Manifestations (Leptospirosis) | 2 , 1 | |
Clinical Manifestations (STD) | 1 | |
Clinical Outcome (Anthrax) | 1 | |
Clinical Syndrome (Arbovirus) | 7 , 6 , 5 , 4 , 3 , 2 , 1 | |
Clinician Observed Lesions (STD) | 1 | |
College Living Situation (RIBD) | 2 , 1 | |
Colony Count Magnitude | 2 , 1 | |
Common-Source Outbreak (Hepatitis A) | 1 | |
Complications (Mumps) | 7 , 6 , 5 | |
Condition Status (FDD) | 2 , 1 | |
Contact Type (Anthrax) | 1 | |
Contact Type (Brucellosis) | 1 | |
Contact Type (COVID-19) | 1 | |
Contact Type (Hepatitis A) | 1 | |
Contact Type (Hepatitis B and C) | 1 | |
Contact Type (RIBD) | 1 | |
Contact Type Hepatitis A (NETSS) | 1 | |
Contributory Tobacco Use (NCHS) | 3 , 2 | |
Country | 6 , 5 , 4 , 3 | |
Country of Product Acquisition (Brucellosis) | 2 , 1 | |
County | 3 , 2 | |
Critical Infrastructure Sector (NND) | 1 | |
Cruise Line (RIBD) | 1 | |
Current Sex (NND) | 1 | |
Darkfield DFA Result (CS) | 1 | |
Data Reporting Source (CO) | 2 , 1 | |
Data Reporting Source (COVID-19) | 1 | |
Day Care Setting (FDD) | 1 | |
Decedent Education Level (NCHS) | 1 | |
Definitely Possibly No (RIBD) | 2 , 1 | |
Delivery Routes (NCHS) | 2 | |
Delivery Type (RIBD) | 1 | |
Detection Method (COVID-19) | 2 , 1 | |
Detection Method (STD) | 2 | |
Diabetes Status | 1 | |
Diagnosed Pneumonia By (VZ) | 1 | |
Diagnosed by (VZ) | 4 , 3 , 2 | |
Diagnostic Lab Test Findings (NND) | 1 | |
Diagnostic Test Finding (Anthrax) | 1 | |
Diet Type (Anthrax) | 1 | |
Directly Observed Therapy (TB) | 1 | |
Discharge Location (RIBD) | 3 , 2 , 1 | |
Disease Acquired Jurisdiction | 3 , 2 , 1 | |
Disease Acquired Jurisdiction (NETSS) | 1 | |
Disease Outcome Type (Leptospirosis) | 2 , 1 | |
Disease Stage (Brucellosis) | 2 , 1 | |
Disposition OPD (NCHS) | 1 | |
Division Vital Statistics (County) | 1 | |
Drinking Water (FDD) | 1 | |
Duration Unit | 2 , 1 | |
Duration Unit (1) | 1 | |
E. coli Shiga Toxin (BIDS) | 1 | |
E. coli Shiga Toxin Test Type (BIDS) | 1 | |
Emergency Department Acuity | 1 | |
Employment Status | 1 | |
Employment Status (Flu) | 1 | |
Epilinked Case Type (VZ) | 5 , 4 , 3 , 2 | |
Establishment Type (RIBD) | 1 | |
Ethnicity (ARLN) | 1 | |
Ethnicity Detail (NCHS) | 2 , 1 | |
Ethnicity Group (NCHS) | 2 , 1 | |
Ethnicity Group including Unknown | 2 , 1 | |
Exposure Location (Brucellosis) | 1 | |
Exposure Risk (Brucellosis) | 1 | |
Exposure Setting (COVID-19) | 2 , 1 | |
Exposure Setting Master (RIBD) | 1 | |
Exposure Site Category (CO) | 4 , 3 , 2 | |
Exposure Source (Anthrax) | 1 | |
Exposure Source (Brucellosis) | 4 , 3 , 2 , 1 | |
Exposure Source (CO) | 3 , 2 , 1 | |
Exposure Type (Leptospirosis) | 1 | |
Extended Race Group (Listeria) | 1 | |
Extreme Weather Type (CO) | 4 , 3 , 2 , 1 | |
Facility Type (RIBD) | 1 | |
Fetal Death Cause or Condition (NCHS) | 1 | |
Fetal Death Time Points (NCHS) | 1 | |
Fetal Neonatal Infection Type (FDD) | 1 | |
Fetal Neonatal Specimen Type | 1 | |
Fetal Outcome (RIBD) | 2 , 1 | |
Fetal Presentations (NCHS) | 3 | |
Fetal Remains Disposition Method (NCHS) | 1 | |
Final Treatment Outcome (TB) | 1 | |
Follow-up Attempt Outcome (NCHS) | 2 , 1 | |
Food Cooking Method (FDD) | 1 | |
Food Cooking Method (Trich) | 1 | |
Food Processing Method (FDD) | 1 | |
Food Processing Method (Trich) | 1 | |
Food Product Consumed (Brucellosis) | 2 , 1 | |
Fresh Berries (FDD) | 2 , 1 | |
Fresh Herbs (FDD) | 2 , 1 | |
Fresh Produce (FDD) | 2 , 1 | |
Fresh Water or Mud Type (Leptospirosis) | 2 , 1 | |
GAS Risk Factor Interval (RIBD) | 1 | |
Gender (ARLN) | 1 | |
Gender Identity | 4 , 3 , 2 , 1 | |
Gender Identity (NNDSS) | 1 | |
Gender Identity (STD) | 1 | |
General Condition Status | 1 | |
Generator Distance (CO) | 3 , 2 | |
Generator Location (CO) | 4 | |
Genotype (Measles) | 1 | |
Genotype (Rubella) | 3 , 2 , 1 | |
Geographic Region (NETSS) | 1 | |
Gestational Age Determination (RIBD) | 2 , 1 | |
Glove Material (RIBD) | 1 | |
H. influenzae Serotype (RIBD) | 1 | |
HBV DNA Test Result (Hepatitis B Perinatal) | 3 , 2 , 1 | |
HBeAg Test Result (Hepatitis B Perinatal) | 1 | |
HBsAg Test Result (Hepatitis B Perinatal) | 1 | |
HIV Diagnosis Based On | 1 | |
HIV Status | 1 | |
HIV Status (STD) | 4 , 3 , 2 , 1 | |
Health Care Practice Type (TB) | 1 | |
Healthcare Exposure Type (RIBD) | 2 , 1 | |
Healthcare Occupation (COVID-19) | 2 , 1 | |
Heated Food (Listeria) | 1 | |
Hispanic Ethnic Group (Listeria) | 1 | |
Hospital Procedure (Leptospirosis) | 2 , 1 | |
IgM Test Type (VZ) | 1 | |
Illness (Listeria) | 2 , 1 | |
Immigration Status | 1 | |
Immunization Funding Source (IIS) | 1 | |
Immunization Information Source (CRS) | 4 , 3 , 2 | |
Infant Anti-HCVTest Result (Hepatitis C Perinatal) | 1 | |
Infant HCV Antigen Test Result (Hepatitis C) | 1 | |
Infant Nucleic Acid Test Result (Hepatitis C) | 1 | |
Infection Type (RIBD) | 1 | |
Injury Occurred Environment (NETSS) | 1 | |
Injury Occurred Environment (VPD) | 1 | |
Injury Type (NETSS) | 1 | |
Injury Type (VPD) | 1 | |
Insurance Type (RIBD) | 1 | |
Intent of Exposure (CO) | 1 | |
Job Setting (COVID-19) | 1 | |
Lab Result (Pertussis) | 1 | |
Lab Result (Rubella) | 1 | |
Lab Test (Hansen) | 2 | |
Lab Test Interpretation | 2 , 1 | |
Lab Test Interpretation (Legionellosis) | 1 | |
Lab Test Interpretation (Pertussis) | 5 , 4 , 3 , 2 , 1 | |
Lab Test Interpretation (RIBD) | 2 , 1 | |
Lab Test Interpretation (TB) | 3 , 2 , 1 | |
Lab Test Interpretation (Trich) | 1 | |
Lab Test Interpretation (VPD) | 7 , 6 , 5 , 4 , 3 , 2 , 1 | |
Lab Test Interpretation (Varicella) | 4 , 3 , 2 , 1 | |
Lab Test Interpretation Master (RIBD) | 1 | |
Lab Test Method (MDRO) | 3 , 2 , 1 | |
Lab Test Method (RIBD) | 2 , 1 | |
Lab Test Procedure (Malaria) | 1 | |
Lab Test Procedure (Rubella) | 6 , 5 , 4 | |
Lab Test Reactivity (NND) | 1 | |
Lab Test Result (PHLIP Flu) | 14 | |
Lab Test Result Interpretation (NND) | 2 | |
Lab Test Result Lyme (NETSS) | 1 | |
Lab Test Result Qualitative (NND) | 3 , 2 | |
Lab Test Result Qualitative (Syphilis) | 1 | |
Lab Test Type (Babesiosis) | 2 | |
Lab Test Type (Mumps) | 6 , 5 | |
Lab Test Type (Pertussis) | 6 , 5 | |
Late Clinical Manifestation (STD) | 1 | |
Legionella Exposure Setting (RIBD) | 2 , 1 | |
Legionellosis Serogroup (RIBD) | 2 , 1 | |
Lettuce Type (FDD) | 2 , 1 | |
Likely Contact (Listeria) | 1 | |
LikelyAte (Listeria) | 1 | |
Location Type (Leptospirosis) | 2 , 1 | |
Manufacturers Of Vaccines (NETSS) | 1 | |
Marital Status HL7 | 1 | |
Maternal Infection (FDD) | 1 | |
Meat Consumed Type (Trich) | 1 | |
Meat Purchase Info (FDD) | 1 | |
Meat Purchase Info (Trich) | 1 | |
Medical History (Listeria) | 1 | |
Medication (Brucellosis) | 1 | |
Medication (Leptospirosis) | 2 , 1 | |
Medication Administered (Anthrax) | 1 | |
Medication Administered (FDD) | 1 | |
Medication Administered (Hansen) | 1 | |
Medication Completed (Brucellosis) | 2 , 1 | |
Medication Missed (Malaria) | 1 | |
Medication Prophylaxis (Malaria) | 5 , 4 , 3 , 2 , 1 | |
Medication Received (Lyme) | 3 | |
Medication Received (TBRD) | 2 | |
Medication Received (VZ) | 3 | |
Medication Route (STD) | 1 | |
Medication Treatment (Malaria) | 5 , 4 , 3 , 2 , 1 | |
Medication Treatment (STD) | 1 | |
Methods of Disposition (NCHS) | 2 , 1 | |
Microorganism (RIBD) | 1 | |
Microorganism (STD) | 1 | |
Microscopic Exam Culture Site (TB) | 3 , 2 , 1 | |
Mode of Delivery (RIBD) | 2 , 1 | |
Molecular Indel (TB) | 1 | |
Molecular Test Methods (TB) | 1 | |
Molecular Test Results (TB) | 1 | |
Mother Nucleic Acid Test Result (Perinatal Hep) | 1 | |
N. meningitidis Serogroup (RIBD) | 2 , 1 | |
Neurological Manifestation (STD) | 2 , 1 | |
No Case Reason (CRS) | 1 | |
Non Pork Type (FDD) | 1 | |
Non-Sterile Specimen (Pediatric Flu) | 1 | |
Non-Treponemal Test Result (STD) | 2 , 1 | |
Null Flavor (HL7 V3) | 1 | |
Number Of Lesions (VZ) | 2 | |
Number Of Sex Partners (Hepatitis) | 1 | |
Number of Cigarettes Smoked per Day (CO) | 1 | |
Occupation Risk Category (TB) | 1 | |
Organism (FDD) | 6 , 5 , 4 , 3 , 2 , 1 | |
Organism Name (Brucellosis) | 1 | |
Other Related Cases | 1 | |
Outbreak Type (FDD) | 2 | |
Oxacillin Interpretation (IPD) | 1 | |
PCR Specimen Source (CRS) | 2 , 1 | |
PCR Specimen Source (VZ) | 3 , 2 | |
Parotitis Laterality (Mumps) | 2 , 1 | |
Passed Failed Unknown | 1 | |
Patient Outcome (Listeria) | 1 | |
Performing Lab Type (Anthrax) | 1 | |
Performing Lab Type (RIBD) | 1 | |
Performing Lab Type (Trich) | 1 | |
Performing Laboratory Type (Leptospirosis) | 1 | |
Performing Laboratory Type (VPD) | 1 | |
Person/Organization Taking CO Reading (CO) | 1 | |
Personal Protective Equipment (RIBD) | 1 | |
Place of Death (NCHS) | 4 , 3 , 2 | |
Poison Control Center Record (CO) | 2 , 1 | |
Pork Type (FDD) | 1 | |
Positive Negative Unknown | 1 | |
Positive Negative Unknown Not Done | 1 | |
Pre-Pregnancy SerologicalTestInterp (CRS) | 2 , 1 | |
Pregnancy Outcome (FDD) | 2 , 1 | |
Pregnancy Outcome (Leptospirosis) | 1 | |
Pregnancy Outcome (Listeria) | 2 , 1 | |
Pregnancy Status (RIBD) | 2 , 1 | |
Pregnancy Treatment Stage (NND) | 1 | |
Pregnancy Trimester | 2 | |
Prenatal Care Provider (Rubella) | 1 | |
Present Absent Unknown Not Examined | 1 | |
Previous Treatment Duration (Hansen) | 1 | |
Primary Reason For Evaluation (TB) | 3 , 2 , 1 | |
Procedure Type (Anthrax) | 1 | |
Public Private Lab | 1 | |
Public Site of Exposure (CO) | 4 , 3 , 2 | |
Quantitative Syphilis Test Result (STD) | 3 , 2 , 1 | |
Race (NCHS) | 2 | |
Race Category including Null Flavor | 1 | |
Race Category including Refused | 1 | |
Race Category including Unknown | 1 | |
Rash Distribution (VZ) | 1 | |
Raw Unpasteurized Products (FDD) | 1 | |
Reason For Test (Hepatitis) | 2 , 1 | |
Reason Medication Not Completed (BSP) | 1 | |
Reason Not Treated with RIPE (TB) | 3 | |
Reason Therapy Stopped (TB) | 3 , 2 , 1 | |
Reason for Hospitalization (VZ) | 3 , 2 , 1 | |
Reason for Missing Test (NND) | 1 | |
Reason for Test (COVID-19) | 1 | |
Recreational H2O Treatment (FDD) | 2 | |
Relationship (Hansen) | 1 | |
Relationship (VPD) | 1 | |
Reporting Source Type | 2 | |
Residence Location (RIBD) | 3 , 2 , 1 | |
Residence Type (COVID-19) | 1 | |
Residential Site of Exposure (CO) | 3 , 2 , 1 | |
Respiratory Protective Equipment (RIBD) | 1 | |
Respondent (Listeria) | 1 | |
Result of Radiology Study (TB) | 1 | |
Risk Factor (COVID-19) | 3 , 2 , 1 | |
Rodent Type (Leptospirosis) | 1 | |
Route of Administration (STD) | 3 | |
SPN/IPD Serotype (RIBD) | 2 , 1 | |
STEC Nonculture Test Type (BIDS) | 1 | |
School Year (RIBD) | 1 | |
Seafood Preparation (FDD) | 2 , 1 | |
Seafood Purchase Info (FDD) | 1 | |
Seafood Source (FDD) | 1 | |
Sequelae (Hansen) | 1 | |
Sequelae (RIBD) | 2 , 1 | |
Serogroup (NETSS) | 1 | |
Serogroup Method (RIBD) | 1 | |
Serotype (Arbovirus) | 1 | |
Serotype (Dengue) | 1 | |
Serotype (NETSS) | 1 | |
Serotype Master (RIBD) | 1 | |
Serotype Method (IPD) | 1 | |
Serotype Method (RIBD) | 1 | |
Setting of Further Spread | 1 | |
Sexual Contact (FDD) | 1 | |
Sexual Orientation | 2 , 1 | |
Sexual Orientation (STD) | 1 | |
Sexual Orientation (USCDI) | 1 | |
Sexual Preference (NETSS) | 1 | |
Shellfish Distributed (FDD) | 1 | |
Sick Animal Type (Leptospirosis) | 1 | |
Signs Symptoms (CS) | 1 | |
Signs and Symptoms (COVID-19) | 2 , 1 | |
Signs and Symptoms (Listeria) | 1 | |
Signs and Symptoms (Measles) | 3 | |
Signs and Symptoms (Mumps) | 3 , 2 | |
Signs and Symptoms (RIBD) | 2 , 1 | |
Signs and Symptoms (Rubella) | 3 | |
Sites of Directly Observed Therapy (TB) | 1 | |
Skin Exposure (FDD) | 1 | |
Smoking Status (Anthrax) | 1 | |
Smoking Status (RIBD) | 1 | |
Source of Laboratory Test (Hepatitis) | 3 , 2 , 1 | |
Specimen Collection Setting Type (C. auris) | 2 , 1 | |
Specimen From Mother Or Infant (CRS) | 2 , 1 | |
Specimen Source (CP-CRE) | 1 | |
Specimen Source (CRS) | 2 | |
Specimen Source (STD) | 2 , 1 | |
Specimen Source Site (Anthrax) | 1 | |
Specimen Source Site (Brucellosis) | 1 | |
Specimen Source Site (Leptospirosis) | 1 | |
Specimen Source Site (VPD) | 1 | |
Specimen Type (Anthrax) | 1 | |
Specimen Type (Brucellosis) | 1 | |
Specimen Type (Leptospirosis) | 2 , 1 | |
Specimen Type (RIBD) | 4 , 3 , 2 , 1 | |
Specimen type (ARLN) | 1 | |
Specimen type (Trich) | 1 | |
Sputum Culture Conversion Not Documented Reason | 2 , 1 | |
States Territories Provinces (NCHS) | 7 , 6 , 5 , 3 , 2 , 1 | |
Stay Period Hepatitis (NETSS) | 1 | |
Sterile Specimen (Pediatric Flu) | 1 | |
Strain Type (Trich) | 3 , 2 , 1 | |
Strain Type (VZ) | 1 | |
Substance Abuse (RIBD) | 3 , 2 , 1 | |
Substance Treatment Refusal Reason | 1 | |
Susceptibility Data NA (RIBD) | 1 | |
Susceptibility Interpretation (RIBD) | 3 | |
Susceptibility Result | 1 | |
Susceptibility Result (IPD) | 1 | |
Susceptibility Test Interpretation (TB) | 2 , 1 | |
Suspected Food Consumed (FDD) | 1 | |
Swimming Pool Type (FDD) | 1 | |
Syphilis Clinical Stage (CS) | 1 | |
Syphilis Neurologic Involvement (STD) | 3 , 2 , 1 | |
Syphilis Surveillance Stage (CS) | 2 , 1 | |
Syphilis Treatment Infant (CS) | 1 | |
Syphilis Treatment Mother (CS) | 1 | |
Tap Water Source (FDD) | 1 | |
Tattoo Obtained From (Hepatitis) | 2 , 1 | |
Test Method (FDD) | 4 , 3 , 2 , 1 | |
Test Method EIA IgM | 1 | |
Test Result (FDD) | 3 , 2 , 1 | |
Test Result (Hepatitis A) | 1 | |
Test Result (Hepatitis) | 1 | |
Test Result Coded Qualitative | 1 | |
Test Results (Brucellosis) | 1 | |
Test Titer Type (Brucellosis) | 1 | |
Test Type (Brucellosis) | 2 , 1 | |
Tetanus Type (VPD) | 1 | |
Therapy Extended Reason (TB) | 3 , 2 | |
Time Period Tetanus (NETSS) | 1 | |
Time Units (NCHS) | 1 | |
Timing of Maternal Treatment (NND) | 2 , 1 | |
Titer Test Method (RIBD) | 1 | |
Titer Test Type (RIBD) | 1 | |
Total Doses of Vaccine (Anthrax) | 1 | |
Transmission Setting (NETSS) | 1 | |
Transmission Setting (NND) | 3 , 2 , 1 | |
Travel Purpose | 2 | |
Travel Purpose (CDC) | 1 | |
Travel Reason (Hepatitis A) | 1 | |
Travel Reason (Malaria) | 4 , 3 , 2 , 1 | |
Treatment Location (CO) | 1 | |
Treatment Outcome Tetanus (VPD) | 1 | |
Treatment Site (CO) | 2 | |
Treatment Type (Anthrax) | 1 | |
Treatment Type (COVID-19) | 2 , 1 | |
Treponemal Serologic Test (STD) | 2 , 1 | |
Tribe Name (NND) | 2 , 1 | |
Type Of Complication (CRS) | 4 , 3 , 2 , 1 | |
Type Of Complication (Rubella) | 4 | |
Type of Complication (Measles) | 2 | |
Type of Complication (STD) | 1 | |
Type of Correctional Facility | 3 , 2 , 1 | |
Type of Deafness (Mumps) | 2 , 1 | |
Type of Long Term Care Facility | 3 , 2 , 1 | |
Type of Testing at CDC | 2 , 1 | |
Type of Testing at CDC (NND) | 1 | |
Type of Testing at CDC (VZ) | 1 | |
Type of Testing at CDC(Rubella) | 1 | |
Underlying Condition (RIBD) | 2 , 1 | |
Underlying Condition(s) (Leptospirosis) | 2 , 1 | |
Underlying Conditions | 1 | |
Underlying Conditions (CO) | 3 , 2 | |
Underlying Conditions (IPD) | 2 | |
Usual Occupation and Industry (TB) | 2 , 1 | |
VDRL Test Result (NND) | 1 | |
VPD Laboratory Coded Observation | 3 , 2 , 1 | |
VPD Specimen Type | 6 , 5 , 4 | |
Vaccination Location (CRA) | 1 | |
Vaccine Doses Received (Pertussis) | 1 | |
Vaccine Doses Received (Tetanus) | 1 | |
Vaccine Event Information Source (NND) | 3 , 2 , 1 | |
Vaccine Exposure (Brucellosis) | 1 | |
Vaccine Not Given Reason | 3 , 2 , 1 | |
Vaccine Not Given Reasons (NETSS) | 1 | |
Vaccines Administered (NETSS) | 1 | |
Vaccines Administered (VZ) | 2 | |
Vibrio Biotype (BIDS) | 1 | |
Vibrio Cholera Biotype (FDD) | 1 | |
Vibrio Cholera Serotype (FDD) | 1 | |
Vibrio Cholera Toxin Test Type (BIDS) | 1 | |
Vibrio Serotype (BIDS) | 1 | |
Vital Records Education Level (NCHS) | 1 | |
Water Salinity (FDD) | 1 | |
Water Source (RIBD) | 1 | |
Well Water Treatment (FDD) | 1 | |
Workers Compensation Record (CO) | 2 , 1 | |
Wound Depth Tetanus (NETSS) | 1 | |
Wound History | 1 | |
X-Ray Result (CS) | 1 | |
YNRD (CDC) | 4 , 3 | |
Yes No Don't Know Maybe (FDD) | 1 | |
Yes No Unknown (YNU) | 1 | |
Yes No Unknown Maybe (FDD) | 1 | |
Yes No Unknown NA (NND) | 1 | |
Yes No Unknown No Answer | 1 | |
Yes No Unknown Not Done | 1 | |
Yes No Unknown Refused (Listeria) | 1 | |
Yes No Unknown Refused (NND) | 1 |
- Page last reviewed:June 20, 2024
- Page last updated:June 20, 2024
- Content source: